Mettler-Toledo International (NYSE:MTD) and Bio-Rad Laboratories (NYSE:BIO) are both large-cap computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.
Insider & Institutional Ownership
93.2% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 63.0% of Bio-Rad Laboratories shares are owned by institutional investors. 3.2% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 27.5% of Bio-Rad Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Risk and Volatility
Mettler-Toledo International has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500.
Profitability
This table compares Mettler-Toledo International and Bio-Rad Laboratories' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
|---|
| Mettler-Toledo International | 19.36% | 144.89% | 21.11% |
| Bio-Rad Laboratories | 147.91% | 3.77% | 2.74% |
Valuation & Earnings
This table compares Mettler-Toledo International and Bio-Rad Laboratories' gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
|---|
| Mettler-Toledo International | $3.01 billion | 9.48 | $561.11 million | $22.77 | 53.69 |
| Bio-Rad Laboratories | $2.31 billion | 7.78 | $1.76 billion | $7.06 | 85.35 |
Bio-Rad Laboratories has lower revenue, but higher earnings than Mettler-Toledo International. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings for Mettler-Toledo International and Bio-Rad Laboratories, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
|---|
| Mettler-Toledo International | 3 | 5 | 1 | 0 | 1.78 |
| Bio-Rad Laboratories | 0 | 0 | 3 | 0 | 3.00 |
Mettler-Toledo International currently has a consensus price target of $971.3750, indicating a potential downside of 20.54%. Bio-Rad Laboratories has a consensus price target of $700.00, indicating a potential upside of 16.17%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.
Summary
Mettler-Toledo International beats Bio-Rad Laboratories on 8 of the 14 factors compared between the two stocks.
